ScholarIQanswers from OpenAlex

Dual energy CT − a possible new method to assess regression of rectal cancers after neoadjuvant treatment

PaperCitations, authors & open-access status

Dual energy CT − a possible new method to assess regression of rectal cancers after neoadjuvant treatment is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Dual energy CT − a possible new method to assess regression of rectal cancers after neoadjuvant treatment have?

ScholarIQcitation count

Dual energy CT − a possible new method to assess regression of rectal cancers after neoadjuvant treatment has 20 citations in the OpenAlex counts ScholarIQ stores.

When was Dual energy CT − a possible new method to assess regression of rectal cancers after neoadjuvant treatment published?

ScholarIQyear

Dual energy CT − a possible new method to assess regression of rectal cancers after neoadjuvant treatment has 2017 year in the ScholarIQ index.

What is the open-access status of Dual energy CT − a possible new method to assess regression of rectal cancers after neoadjuvant treatment?

ScholarIQoa status

Dual energy CT − a possible new method to assess regression of rectal cancers after neoadjuvant treatment has green oa status in the ScholarIQ index.

What is the DOI of Dual energy CT − a possible new method to assess regression of rectal cancers after neoadjuvant treatment?

ScholarIQdoi

The DOI for Dual energy CT − a possible new method to assess regression of rectal cancers after neoadjuvant treatment is on the source record.

What is the PMID of Dual energy CT − a possible new method to assess regression of rectal cancers after neoadjuvant treatment?

ScholarIQpmid

The PMID for Dual energy CT − a possible new method to assess regression of rectal cancers after neoadjuvant treatment is on the source record.

What is the OpenAlex record for Dual energy CT − a possible new method to assess regression of rectal cancers after neoadjuvant treatment?

ScholarIQopenalex

The OpenAlex for Dual energy CT − a possible new method to assess regression of rectal cancers after neoadjuvant treatment is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial